Endpoints
Capricor Claims FDA Misinterpreted Efficacy Data Leading to Rejection of DMD Therapy
Capricor Therapeutics; FDA rejection; deramiocel; Duchenne muscular dystrophy (DMD); efficacy data misinterpretation; clinical trial endpoints; HOPE-2 trial; non-parametric test; statistical significance; cell therapy
Endpoints News to Announce 2025 ‘Endpoints 11’ Biotechs to Watch Live in Boston
Endpoints 11; biotech startups; biopharma; Boston; live event; industry trends; biotech innovation
FDA Announces New Rare Disease Approval Programme
FDA; rare disease; conditional approval pathway; accelerated approval; biologics; drug review; surrogate endpoints; real-world data; streamlined process
How Past Endpoints 11 Winners Fared During the 2025 Biotech Downturn
Endpoints 11; biotech downturn 2025; biotech winners; Xaira Therapeutics; biotech awards; industry trends
Endpoints 11: Biopharma’s most promising startups revealed live in Boston this September
Endpoints 11; biotech startups; biopharma; Boston event; State Room; awards gala; early bird rate; industry insiders; 2025 most promising biotechs; real-time reveal
Endpoints 11: The Most Promising Biotech Companies to Watch in 2025 Revealed Live in Boston
Endpoints 11; biotech companies; Boston; biotech awards; biotech industry
May the (Power of the) Pool be with you: Accelerating time from DNA to GMP – STI-based CLD Platform
DNA to GMP; STI-based CLD Platform; bioprocessing; Endpoints News; webinar; cell line development; biopharma; time acceleration
Keytruda and Lenvima Combination Shows Mixed Results in Gastroesophageal Cancer Trial
Keytruda, Lenvima, gastroesophageal cancer, clinical trial, survival endpoints, progression-free survival, overall survival
Medidata Introduces Bundled Solutions for Oncology and Vaccine Trials to Enhance Study Efficiency
Medidata, Oncology Trials, Vaccine Trials, Bundled Solutions, Clinical Trial Efficiency, Patient-Centered Endpoints, Adaptive Trial Designs, Trial Diversity